Print

Certain Hormonal Contraceptive May Pose Risk of Type 2 Diabetes for Obese Women, University of Southern California Study  
2/8/2013 7:26:52 AM

A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.
//-->